Sign In
NewsRadar

Life Sciences Partners (LSP)

Life Sciences Partners ("LSP") is a leading European venture capital fund, providing private equity capital to early stage life sciences companies. Based in Amsterdam and Munich, LSP’s management has focused for over a decade on investing in human life sciences.


• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Johannes Vermeerplein 9
Amsterdam  1071 DV
Netherlands
+31 (0) 20 664 55 00
+31 (0) 20 676 88 10
http:///www.lsp.nl
Martijn Kleijwegt
+31 (0) 20 664 55 00

Company Facts
Type:
Capital managed:
Companies invested in:  
Investment managers:
Total staff size:
Number of offices:
Min. investment size:
Max. investment size:
Independent Investor (VC)
370 Mln Euro



3

Funding stages:Startups, Early Stages, Expansion
Geo. scope europe:North Europe, West Europe, Central Europe, South Europe
Investment distrib.:
Industry preferences:Other

Partners

  • Joachim Rothe
  • Jörg Neermann
  • Mark Wegter
  • Martijn Kleijwegt
  • René Kuijten
  • Tom Schwarz

    Portfolio

    Funds
    NameStatusClosingSize
    LSP BioventuresClosedJul 2006150 Mln Euro

    Remarks
    LSP invests in life sciences companies. Geographical Focus: Benelux and German-speaking countries


  • Data


    24,413
    Tech investments
    From our Online Data Service
    15,788
    VC-backed companies
    From our Radar


    Recent Deals


    DATEAMOUNTSECTOR
    Jun 19€13.0MInternet services
    Jun 19€2.5MOther Biotechnology & Healthcare
    Jun 19€5.0MMedical devices
    Jun 18€3.0MSecurity
    Jun 18€12.0MApplication integration
    Jun 18€2.0MContent management
    Jun 18€1.6MContent distribution

    For information on Europe's most extensive database on technology funding click here!

    Events



    Press Releases


    Mar 29
    Addex Therapeutics
    addex sucessfully raises chf40 million in capital increase

    Jan 2
    Urban Jungle
    urban jungle raises 1m in seed funding to build tech-enabled home ...

    Aug 17
    Komed Health
    komed health closes seed financing round

    Jul 10
    Komed Health
    komed health to be supported by nokia and deutsche telekom

    May 4
    Vivet Therapeutics
    vivet therapeutics raises 37.5 million in series a





    About usContact usLegal Information
    Copyright 1999-2018
    Emerging Technology Research Europe Inc. All rights reserved.